
TSE:BNS
This summary was created by AI, based on 30 opinions in the last 12 months.
The Bank of Nova Scotia (BNS) has elicited mixed reviews from experts. Some highlight its strong positioning for future growth due to investments in GenAI and a favorable regulatory environment that allows for increased lending capacity. However, others express concerns about BNS's performance relative to its Canadian peers, noting it as the weakest among them despite a decent dividend yield of around 4.5% and recent strategic moves to invest in the U.S. market through KEY. While some analysts see potential for long-term gains, particularly with the new CEO at the helm, others urge caution citing stagnant loan growth and rising provisions for credit losses (PCLs). The overall sentiment reflects a blend of optimism for its turnaround and skepticism about its ability to catch up to its competitors amidst ongoing economic challenges.
Which Canadian bank should I choose? You could probably pick them all, but if you wanted to pick one only, he would pick Bank of Nova Scotia (BNS-T). Their International side is coming along. They are pretty good at wielding the scalpel, so costs are always a good area of focus for them. Expects the group will grow at 8%-9%.
Canadian banks have done tremendously well over the last 10 years. The regulators are doing a great job of making sure the industry is safe. Everyone should own banks. There has not been any big write-downs in the banks recently. They are firing on all cylinders. Don’t overpay for them. BNS-T has international exposures to commodities, which has held them back a bit.
Toronto Dominion (TD-T), Bank of Montréal (BMO-T) or Bank of Nova Scotia (BNS-T)? He likes the financials. In Canada, the banks and insurers have underperformed the rest of the sectors this year. Interest rates starting to move higher is good for banks. This bank has a lot of their revenues coming from international markets and this is a good name. He would prefer a combination of TD and this bank.
Today you are buying this for Price/Book that is in the middle of the pack. Looking forward, it is at about 11X forward earnings. This has done a lot of restructuring over the last couple of years. They’ve put a lot of money into IT, and benefits have begun to show in the last quarter. Dividend yield of 4%. (Analysts’ price target is $85.)
Brookfield Infrastructure (BIP.UN-T) or Bank of Nova Scotia (BNS-T) for better growth? Financials is a group that he has been in favour of for some time, but prefers US to Canadian. All banks will benefit if we wind up in a rate rise cycle, but Canadian banks probably less likely. If he had to buy one of these 2, he would probably buy Brookfield Infrastructure.
Canadian banks have all been affected by Home Capital (HCG-T), and this is now back to an average valuation. It is 50% international and 50% Canadian, so you don’t have to worry about the US president doing anything crazy. They are really starting to get their act together in the last few quarters in a couple of the South American countries. The stock has had a 10% pullback, Dividend yield of 4%. (Analysts’ price target is $85.)
TD-T vs. BNS-T. He has a small exposure to the Canadian banking sector, but is more exposed to the Canadian insurance sector. His preference is BNS-T because it has the smallest footprint in Canada. A lot of growth is dependent on capital markets. TD-T has a big US exposure and he likes that, but these are not his choice.
(A Top Pick June 2/16. Up 21%.) This bank has had tremendous focus on cost control, as well as technology development, over the last few years. The new CEO has made them more competitive in a modern environment. The most internationally diversified of all the Canadian banks. It has great exposure to South America, so if there is an uptick in materials, etc., that will do very well for them. Still a Buy. (See Top Picks.)
It is 50% Canadian retail and 50% international which he likes. It means it has a higher growth rate. It is in the middle of the range for earnings. There is a dividend increase coming this quarter probably. (Analysts’ target: $85.00).